SLGC
Market cap | $0.00 |
---|---|
Enterprise Value | $-288,905,000.00 |
Dividend Yield | $0 (0%) |
Earnings per Share | $-0.59 |
Beta | 1.64 |
Outstanding Shares | 187,070,510 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -3.01 |
---|---|
PEG | 9.2 |
Price to Sales | - |
Price to Book Ratio | 1.05 |
Enterprise Value to Revenue | -3.54 |
Enterprise Value to EBIT | 1.97 |
Enterprise Value to Net Income | 2 |
Total Debt to Enterprise | -0.06 |
Debt to Equity | 0.03 |
No data
No data
CM Life Sciences II Inc. is a blank check company formed for the purpose of effecting a business combination. The Company intends to focus its search for business combination targets in three separate areas of the life sciences industry ...